|
|
|
|
|
|
|
||
ARTICLE |
CORRESPONDENCE Christine A. Biron: Christine_Biron{at}brown.edu
The best-characterized type 1 interferon (IFN) signaling pathway depends on signal transducer and activator of transcription 1 (STAT1) and STAT2. The cytokines can, however, conditionally activate all STATs. Regulation of their access to particular signaling pathways is poorly understood. STAT4 is important for IFN-
induction, and NK cells are major producers of this cytokine. We report that NK cells have high basal STAT4 levels and sensitivity to type 1 IFN–mediated STAT4 activation for IFN- production. Increases in STAT1, driven during viral infection by either type 1 IFN or IFN-, are associated with decreased STAT4 access. Both STAT1 and STAT2 are important for antiviral defense, but STAT1 has a unique role in protecting against sustained NK cell IFN- production and resulting disease. The regulation occurs with an NK cell type 1 IFN receptor switch from a STAT4 to a STAT1 association. Thus, a fundamental characteristic of NK cells is high STAT4 bound to the type 1 IFN receptor. The conditions of infection result in STAT1 induction with displacement of STAT4. These studies elucidate the critical role of STAT4 levels in predisposing selection of specific signaling pathways, define the biological importance of regulation within particular cell lineages, and provide mechanistic insights for how this is accomplished in vivo.
/ß receptor; LCMV, lymphocytic choriomeningitis virus; rm, recombinant mouse; SOCS, suppressor of cytokine signaling; STAT, signal transducer and activator of transcription. M.P. Gil and X. Wang contributed equally to this work.
J. Louten's present address is Schering-Plough Biopharma, Palo Alto, CA 94304.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
| TABLE OF CONTENTS |
|
